David Yaffe
Affiliations: | Cell Biology | Weizmann Institute of Science, Rehovot, Israel |
Google:
"David Yaffe"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Sarig R, Fuchs O, Tencer L, et al. (2010) Cloned myogenic cells can transdifferentiate in vivo into neuron-like cells. Plos One. 5: e8814 |
| Daoud F, Candelario-Martínez A, Billard JM, et al. (2009) Role of mental retardation-associated dystrophin-gene product Dp71 in excitatory synapse organization, synaptic plasticity and behavioral functions. Plos One. 4: e6574 |
| Fort PE, Sene A, Pannicke T, et al. (2008) Kir4.1 and AQP4 associate with Dp71- and utrophin-DAPs complexes in specific and defined microdomains of Müller retinal glial cell membrane. Glia. 56: 597-610 |
| Taghli-Lamallem O, Akasaka T, Hogg G, et al. (2008) Dystrophin deficiency in Drosophila reduces lifespan and causes a dilated cardiomyopathy phenotype. Aging Cell. 7: 237-49 |
| Shcherbata HR, Yatsenko AS, Patterson L, et al. (2007) Dissecting muscle and neuronal disorders in a Drosophila model of muscular dystrophy. The Embo Journal. 26: 481-93 |
| Sarig R, Baruchi Z, Fuchs O, et al. (2006) Regeneration and transdifferentiation potential of muscle-derived stem cells propagated as myospheres. Stem Cells (Dayton, Ohio). 24: 1769-78 |
| Neuman S, Kovalio M, Yaffe D, et al. (2005) The Drosophila homologue of the dystrophin gene - introns containing promoters are the major contributors to the large size of the gene. Febs Letters. 579: 5365-71 |
| de León MB, Montañez C, Gómez P, et al. (2005) Dystrophin Dp71 expression is down-regulated during myogenesis: role of Sp1 and Sp3 on the Dp71 promoter activity. The Journal of Biological Chemistry. 280: 5290-9 |
| Dalloz C, Sarig R, Fort P, et al. (2003) Targeted inactivation of dystrophin gene product Dp71: phenotypic impact in mouse retina. Human Molecular Genetics. 12: 1543-54 |
| Leibovitz S, Meshorer A, Fridman Y, et al. (2002) Exogenous Dp71 is a dominant negative competitor of dystrophin in skeletal muscle. Neuromuscular Disorders : Nmd. 12: 836-44 |